Effects of euglycemic hyperinsulinemia and lipid infusion on circulating cholecystokinin

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 6, 2008, Pages 2328-2333

  Weickert, Martin O ^a,b   Mohlig M ^a,b   Spranger, J ^a,b   Schofl C ^a,b,d   Loeffelholz, C V ^a   Riepl, R L ^c,e   Otto, B ^c   Pfeiffer, A F H ^a,b  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e Department of Gastroenterology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; FATTY ACID; GLUCOSE; HEPARIN; LIPID; SODIUM CHLORIDE;

ADULT; ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 45149110180     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2787     Document Type: Article

References (27)

1. Rushakoff RA, Goldfine ID, Beccaria LJ, Mathur A, Brand RJ, Liddle RA 1993 Reduced postprandial cholecystokinin (CCK) secretion in patients with noninsulin-dependent diabetes mellitus: evidence for a role for CCK in regulating postprandial hyperglycemia. J Clin Endocrinol Metab 76:489-493
2. Bucceri AM, Calogero AE, Brogna A 2002 Gallbladder and gastric emptying: relationship to cholecystokininemia in diabetics. Eur J Intern Med 13:123-128
3. Chandra R, Liddle RA 2007 Cholecystokinin. Curr Opin Endocrinol Diabetes Obes 14:63-67
4. Rehfeld JF 1998 How to measure cholecystokinin in tissue, plasma and cerebrospinal fluid. Regul Pept 78:31-39
5. Bellissimo N, Anderson GH 2003 Cholecystokinin-A receptors are involved in food intake suppression in rats after intake of all fats and carbohydrates tested. J Nutr 133:2319-2325
6. Rayner CK, Park HS, Doran SM, Chapman IM, Horowitz M 2000 Effects of cholecystokinin on appetite and pyloric motility during physiological hyperglycemia. Am J Physiol Gastrointest Liver Physiol 278:G98-G104
7. Liddle RA, Rushakoff RJ, Morita ET, Beccaria L, Carter JD, Goldfine ID 1988 Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans. J Clin Invest 81:1675-1681
8. Ahren B, Holst JJ, Efendic S 2000 Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes. J Clin Endocrinol Metab 85:1043-1048
9. Rehfeld JF 2004 Clinical endocrinology and metabolism. Cholecystokinin. Best Pract Res Clin Endocrinol Metab 18:569-586
10. Green GM 2008 Unique activities of cholecystokinin-58; physiological and pathological relevance. Curr Opin Endocrinol Diabetes Obes 15:48-53
11. Jonkers IJ, Smelt AH, Ledeboer M, Hollum ME, Biemond I, Kuipers F, Stellaard F, Boverhof R, Meinders AE, Lamers CH, Masclee AA 2003 Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. Gut 52:109-115
12. Weickert MO, Loeffelholz CV, Roden M, Chandramouli V, Brehm A, Nowotny P, Osterhoff MA, Isken F, Spranger J, Landau BR, Pfeiffer AF, Mohlig M 2007 A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects. Am J Physiol Endocrinol Metab 293:E1078-E1084
13. Riepl RL, Fiedler F, Ernstberger M, Teufel J, Lehnert P 1996 Effect of intraduodenal taurodeoxycholate and L-phenylalanine on pancreatic secretion and on gastroenteropancreatic peptide release in man. Eur J Med Res 1:499-505
14. Huynh J, Feldt LS 1976 Estimation of box correction for degrees of freedom from sample data in randomized block and split-splot designs. J Ed Stat 69-82
15. Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA 1985 Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest 75:1144-1152
16. Couillard C, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, Mauriege P, Despres JP 1998 Postprandial triglyceride response in visceral obesity in men. Diabetes 47:953-960
17. Stumvoll M, Jacob S, Wahl HG, Hauer B, Loblein K, Grauer P, Becker R, Nielsen M, Renn W, Haring H 2000 Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in humans. J Clin Endocrinol Metab 85:3740-3745
18. Tushuizen ME, Diamant M, Heine RJ 2005 Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes. Postgrad Med J 81:1-6
19. Weickert MO, Pfeiffer AF 2006 Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia 49:1732-1741
20. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA 1983 Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72:1737-1747
21. Boden G, Lebed B, Schatz M, Homko C, Lemieux S 2001 Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50:1612-1617
22. Kong MF, King P, Macdonald IA, Blackshaw PE, Perkins AC, Armstrong E, Buchanan KD, Tattersall RB 1998 Effect of euglycaemic hyperinsulinaemia on gastric emptying and gastrointestinal hormone responses in normal subjects. Diabetologia 41:474-481
23. de Boer SY, Masclee AA, Jebbink MC, Schipper J, Jansen JB, Lamers CB 1992 Effect of intravenous fat on cholecystokinin secretion and gallbladder motility in man. JPEN J Parenter Enteral Nutr 16:16-19
24. Gielkens HA, Lam WF, Coenraad M, Frolich M, van Oostayen JA, Lamers CB, Masclee AA 1998 Effect of insulin on basal and cholecystokinin- stimulated gallbladder motility in humans. J Hepatol 28:595-602
25. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Muller-Wieland D, Kahn CR 2000 Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122-2125
26. Tanaka T, Katsuma S, Adachi T, Koshimizu TA, Hirasawa A, Tsujimoto G, Free fatty acids induce cholecystokinin secretion through GPR120. Naunyn Schmiedebergs Arch Pharmacol, 2007 Oct 31 [Epub ahead of print]
27. Green GM 1994 Feedback inhibition of cholecystokinin secretion by bile acids and pancreatic proteases. Ann NY Acad Sci 713:167-179